UVP.F · AusCann Group Holdings Ltd

-

Please sign in to comment on UVP.F

1 Comment

Admin

4 years, 1 month ago

AusCann Group Holdings Ltd is currently in a long term downtrend where the price is trading 28.7% below its 200 day moving average.

From a valuation standpoint, the stock is 1121.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 16048.4.

Finally, its free cash flow grew by 20.1% to $-2M since the same quarter in the previous year.

Based on the above factors, AusCann Group Holdings Ltd gets an overall score of 1/5.

Exchange	F
CurrencyCode	EUR
ISIN	AU000000AC89
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	12M
PE Ratio	None
Target Price	None
Dividend Yield	0.0%
Beta	1.57

ABOUT

AusCann Group Holdings Ltd

AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.

UVP.F · AusCann Group Holdings Ltd

-

AusCann Group Holdings Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest AusCann Group Holdings Ltd using a moving average strategy